Your browser doesn't support javascript.
loading
Mdm2-mediated ubiquitination of PKCßII is responsible for insulin-induced heterologous desensitization of dopamine D3 receptor.
Zeng, Xingyue; Wu, ChengYan; Cao, Yongkai; Li, Huijun; Zhang, Xiaohan.
Afiliação
  • Zeng X; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.
  • Wu C; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.
  • Cao Y; Department of Neurology, Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, China.
  • Li H; Department of Pharmaceuticals, People's Hospital of Zunyi City Bo Zhou District, China.
  • Zhang X; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.
FEBS Lett ; 598(4): 400-414, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38302840
ABSTRACT
The insulin and dopaminergic systems in the brain are associated with schizophrenia and Parkinson's disease with respect to etiology and treatment. The present study investigated the crosstalk between the insulin receptor (IR) and dopamine receptor and found that insulin stimulation selectively inhibits signaling of D3 R in a PKCßII-dependent manner. Upon insulin stimulation, E3 ligase enzyme Mdm2 moves out of the nucleus to ubiquitinate PKCßII. Subsequently, ubiquitinated PKCßII translocates to the cell membrane and interacts with D3 R in a phosphorylation-dependent manner at S229/257, resulting in the attenuation of D3 R signaling and initiating clathrin-mediated endocytosis and downregulation. Considering that both IR and D3 R are closely related to some neuropsychosis, this study could provide new molecular insight into the etiology of the disorder.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dopamina / Insulinas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dopamina / Insulinas Idioma: En Ano de publicação: 2024 Tipo de documento: Article